Overall rank by patents
#47,844
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Integra Lifesciences NR Ireland Limited
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, active 2017–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
5
Total patents granted
3
CPC technology areas
7.6
Avg claims per patent
-75%
5-year filing velocity
The verdict
Integra holds 5 US patents across 3 technology areas, rank #47,844 of 50,000 tracked assignees.
- #47,844
- of 50,000 US assignees by volume
- Top 96%
- by Innovation Score (16.9/100)
- 7.6
- avg claims per patent
- -75%
- filing velocity, last 5 yrs
Portfolio overview
Integra Lifesciences NR Ireland Limited has been granted 5 US utility patents between 2017 and 2020, placing Integra Lifesciences NR Ireland Limited at rank #47,844 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Integra Lifesciences NR Ireland Limited is one of the more focused assignees in the PatentsView dataset. By volume, Integra sits between Institute Of New Materials, Guangdong Academy Of Sciences (5 patents, rank #47,840) and Integrity Tracking, Llc (5 patents, rank #47,848) - the closest US assignees by grant volume. The composite Innovation Score of 16.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 4 in the 2015–2019 window, a -75% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Integra Lifesciences NR Ireland Limited's 7.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Integra Lifesciences NR Ireland Limited against peers pursuing similar technology classes.
Who files at Integra's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Institute of New…
Institute of New Materials, Guangdong Academy of Sciences
5 patents
- Instytut Technolo…
Instytut Technologii Materialow Elektronicznych
5 patents
- Insurance Zebra
Insurance Zebra Inc.
5 patents
- Integer Health
Integer Health Technologies, LLC
5 patents
- Integrated Magnet…
Integrated Magnetoelectronics Corp.
5 patents
- Integrated Monito…
Integrated Monitoring Systems, LLC
5 patents
- Integrated Soluti…
Integrated Solutions, Inc.
5 patents
- Integrity Tracking
Integrity Tracking, LLC
5 patents
- Integra Lifescien… ◀
Integra LifeSciences NR Ireland Limited
5 patents
What this shows Integra holds 5 patents at rank #47,844, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Integra
By rank, the assignees closest to #47,844 in granted patent volume.
- Institute Of New Materials, Guangdong Academy Of Sciences #47,840 · 5 patents
- Instytut Technologii Materialow Elektronicznych #47,841 · 5 patents
- Insurance Zebra Inc. #47,842 · 5 patents
- Integer Health Technologies, Llc #47,843 · 5 patents
- Integrated Magnetoelectronics Corp. #47,845 · 5 patents
- Integrated Monitoring Systems, Llc #47,846 · 5 patents
- Integrated Solutions, Inc. #47,847 · 5 patents
- Integrity Tracking, Llc #47,848 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Integra's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Integra's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
17 Top 96% higher than 4% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2018 | 2 | 40.0% |
| 2019 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
Which technologies does Integra Lifesciences NR Ireland Limited patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Integra Lifesciences NR Ireland Limited hold?
Integra Lifesciences NR Ireland Limited holds 5 US granted patents filed between 2017 and 2020, spanning 3 technology areas.
What is Integra Lifesciences NR Ireland Limited's Innovation Score?
Integra Lifesciences NR Ireland Limited has an Innovation Score of 16.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Integra Lifesciences NR Ireland Limited focus on?
Integra Lifesciences NR Ireland Limited's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 2 patents. The company has filed patents in 3 CPC subclasses total.
Is Integra Lifesciences NR Ireland Limited's patent filing rate increasing or decreasing?
Integra Lifesciences NR Ireland Limited's recent filing velocity is -75% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Integra Lifesciences NR Ireland Limited's patents?
Integra Lifesciences NR Ireland Limited's patents average 7.6 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Integra Lifesciences NR Ireland Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Integra's 5 grants land it in the top 96% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Integra ranks #47,844 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.